Rice Hall James & Associates LLC increased its stake in Docebo Inc. (NASDAQ:DCBO - Free Report) by 30.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 143,949 shares of the company's stock after purchasing an additional 33,759 shares during the period. Rice Hall James & Associates LLC owned approximately 0.48% of Docebo worth $4,133,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Quantbot Technologies LP bought a new position in shares of Docebo in the fourth quarter worth approximately $132,000. Tower Research Capital LLC TRC increased its position in shares of Docebo by 46.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,983 shares of the company's stock worth $134,000 after purchasing an additional 949 shares during the last quarter. Deutsche Bank AG bought a new position in shares of Docebo in the fourth quarter worth approximately $242,000. Dynamic Technology Lab Private Ltd bought a new position in shares of Docebo in the fourth quarter worth approximately $255,000. Finally, State of Wyoming bought a new position in shares of Docebo in the fourth quarter worth approximately $275,000. 53.17% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts have issued reports on DCBO shares. National Bank Financial lowered Docebo from an "outperform" rating to a "sector perform" rating in a research note on Friday, May 9th. Scotiabank cut their target price on Docebo from $45.00 to $40.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. Cantor Fitzgerald started coverage on Docebo in a research note on Monday, June 9th. They issued an "overweight" rating and a $35.00 target price for the company. Needham & Company LLC reaffirmed a "buy" rating and issued a $42.00 target price on shares of Docebo in a research note on Thursday, April 10th. Finally, Atb Cap Markets lowered Docebo from a "strong-buy" rating to a "hold" rating in a research note on Sunday, May 11th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $44.13.
Read Our Latest Stock Report on DCBO
Docebo Trading Down 0.7%
Shares of NASDAQ:DCBO traded down $0.20 during trading on Tuesday, reaching $28.74. 80,528 shares of the company traded hands, compared to its average volume of 79,245. The firm has a market capitalization of $833.75 million, a price-to-earnings ratio of 38.84 and a beta of 1.48. Docebo Inc. has a 52-week low of $25.50 and a 52-week high of $53.86. The business's fifty day moving average is $27.58 and its 200-day moving average is $32.95.
Docebo Profile
(
Free Report)
Docebo Inc operates as a learning management software company that provides artificial intelligence (AI)-powered learning platform in North America and internationally. It offers Learning Management System (LMS) to train internal and external workforces, partners, and customers. The company's cloud platform consists of a learning suite, which includes Docebo Learn LMS, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Shape, an AI-based learning content creation tool, which enables learning administrators to turn internal and external resources into engaging, multilingual, and microlearning content to share across the business; Docebo Content that allows off-the-shelf learning content by partnering content specialist; Docebo Learning Impact, a learning measurement tool that enables administrators to prove and improve training programs; Docebo Learn Data, which gives a comprehensive view on learning data to business results; Docebo Connect that connects Docebo to custom tech stack and making integrations; and Docebo Flow that allows businesses to directly inject learning into the flow of work.
Recommended Stories

Before you consider Docebo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docebo wasn't on the list.
While Docebo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.